Clinical Trials Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jun 14, 2015; 21(22): 6965-6973
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.6965
Figure 1
Figure 1 Study flow diagram. Only patients whose symptoms resolved after 8 or 2 wk of treatment entered the 24-wk maintenance/on-demand period. CG: Chronic gastritis.
Figure 2
Figure 2 Efficacy of 8-wk and 2-wk regimens. ITT: Intention-to-treat; MITT: Modified intention-to-treat.
Figure 3
Figure 3 Kaplan-Meier survival curves showing time-to-first-relapse of gastro-esophageal reflux disease symptoms (modified intention-to-treat population). GERD: Gastro-esophageal reflux disease; MITT: Modified intention-to-treat.